![Luke Power](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luke Power
Directeur Financier/CFO chez
CARIS LIFE SCIENCES, INC.
Fortune : 2 M $ au 31/07/2026
Profil
Mr. Luke Power is a Chief Financial & Accounting Officer, Senior VP at Caris Life Sciences, Inc. Mr. Power was previously employed as a Manager by PricewaterhouseCoopers LLP.
He received his undergraduate degree from Waterford Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/05/2026 | 153 771 ( 0,05 % ) | 2 M $ | 31/07/2026 |
Postes actifs de Luke Power
| Sociétés | Poste | Début |
|---|---|---|
| CARIS LIFE SCIENCES, INC. | Directeur Financier/CFO | 01/02/2023 |
Anciens postes connus de Luke Power
| Sociétés | Poste | Fin |
|---|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Corporate Officer/Principal | 01/10/2011 |
Formation de Luke Power
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
99
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Waterford Institute of Technology
 Waterford Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Caris Life Sciences, LLC
 Caris Life Sciences, LLC BiotechnologyHealth Technology Operates as an AI-powered biotech company that provides molecular profiling services to develop oncology pharmaceuticals with proprietary platform | Health Technology |
